Royce & Associates’s ArcBest ARCB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.14M Sell
21,758
-48,488
-69% -$4.59M 0.02% 570
2025
Q4
$5.21M Sell
70,246
-27,571
-28% -$1.96M 0.05% 458
2025
Q3
$6.83M Sell
97,817
-18,323
-16% -$1.38M 0.07% 400
2025
Q2
$8.94M Buy
116,140
+17,984
+18% +$1.17M 0.09% 318
2025
Q1
$6.93M Buy
98,156
+12,971
+15% +$1.12M 0.08% 382
2024
Q4
$7.95M Buy
85,185
+7,602
+10% +$804K 0.07% 386
2024
Q3
$8.41M Sell
77,583
-7,061
-8% -$775K 0.08% 356
2024
Q2
$9.06M Sell
84,644
-355
-0.4% -$42.8K 0.08% 336
2024
Q1
$12.1M Sell
84,999
-12,639
-13% -$1.66M 0.11% 271
2023
Q4
$11.7M Sell
97,638
-4,937
-5% -$547K 0.11% 267
2023
Q3
$10.4M Sell
102,575
-21,122
-17% -$2.22M 0.11% 270
2023
Q2
$12.2M Buy
123,697
+5,171
+4% +$462K 0.12% 242
2023
Q1
$11M Buy
118,526
+275
+0.2% +$24.7K 0.11% 278
2022
Q4
$8.28M Buy
118,251
+10,692
+10% +$826K 0.09% 344
2022
Q3
$7.82M Sell
107,559
-21,293
-17% -$1.71M 0.09% 325
2022
Q2
$9.07M Sell
128,852
-42,037
-25% -$3.09M 0.09% 308
2022
Q1
$13.8M Buy
170,889
+56,836
+50% +$5.13M 0.12% 264
2021
Q4
$13.7M Sell
114,053
-149,548
-57% -$15.2M 0.1% 310
2021
Q3
$21.6M Sell
263,601
-39,851
-13% -$2.63M 0.16% 181
2021
Q2
$17.7M Buy
303,452
+77,427
+34% +$5.54M 0.12% 284
2021
Q1
$15.9M Sell
226,025
-166,874
-42% -$9.62M 0.11% 318
2020
Q4
$16.8M Buy
392,899
+37,964
+11% +$1.44M 0.14% 222
2020
Q3
$11M Sell
354,935
-75,488
-18% -$2.35M 0.12% 257
2020
Q2
$11.4M Sell
430,423
-75,063
-15% -$1.61M 0.13% 226
2020
Q1
$8.86M Sell
505,486
-37,028
-7% -$852K 0.12% 224
2019
Q4
$15M Buy
542,514
+105,795
+24% +$3.06M 0.13% 211
2019
Q3
$13.3M Sell
436,719
-216,754
-33% -$6.24M 0.12% 232
2019
Q2
$18.4M Sell
653,473
-91,331
-12% -$2.65M 0.17% 158
2019
Q1
$22.9M Buy
744,804
+743,894
+81,747% +$26.8M 0.19% 125
2018
Q4
$31K Buy
910
+165
+22% +$6.39K ﹤0.01% 1047
2018
Q3
$36K Buy
745
+280
+60% +$13.1K ﹤0.01% 1070
2018
Q2
$21K Buy
465
+81
+21% +$3.34K ﹤0.01% 1113
2018
Q1
$12K Buy
+384
New +$13.4K ﹤0.01% 1145
2016
Q1
Sell
-8,695
Closed -$186K 1096
2015
Q4
$186K Sell
8,695
-23,500
-73% -$580K ﹤0.01% 1074
2015
Q3
$830K Sell
32,195
-188,586
-85% -$5.68M ﹤0.01% 989
2015
Q2
$7.02M Hold
220,781
0.03% 648
2015
Q1
$8.37M Sell
220,781
-5,100
-2% -$206K 0.03% 636
2014
Q4
$10.5M Sell
225,881
-175,439
-44% -$7.12M 0.04% 576
2014
Q3
$15M Sell
401,320
-190,200
-32% -$7.21M 0.05% 454
2014
Q2
$25.7M Sell
591,520
-75,900
-11% -$3.08M 0.08% 319
2014
Q1
$24.7M Buy
667,420
+21,200
+3% +$723K 0.07% 321
2013
Q4
$21.8M Sell
646,220
-149,100
-19% -$4.44M 0.06% 372
2013
Q3
$20.4M Sell
795,320
-630,900
-44% -$15.1M 0.06% 368
2013
Q2
$32.7M Buy
+1,426,220
New +$22.1M 0.1% 248

Other funds holding ARCB

Royce & Associates's ARCB Position: Q1 2026 in Review

Royce & Associates reduced its ArcBest (ARCB) stake by 69% in Q1 2026, selling an estimated $4.59M and leaving 21,758 shares worth $2.14M. The position accounts for 0.02% of the portfolio, ranked #570.

Royce & Associates first reported a position in ARCB in Q2 2013 and has held it in 44 quarters since. The position peaked at $32.7M in Q2 2013. 277 funds tracked by Wall St. Rank hold ARCB as of Q1 2026.

  • Royce & Associates held 21,758 shares of ArcBest worth $2.14M as of Q1 2026.
  • Royce & Associates sold 48,488 ArcBest shares in Q1 2026, an estimated $4.59M.
  • ArcBest made up 0.02% of Royce & Associates's portfolio in Q1 2026, its #570 holding.
  • Royce & Associates first reported a position in ArcBest in Q2 2013 and has held it in 44 quarters since.
  • Royce & Associates's ArcBest position peaked at $32.7M in Q2 2013.
  • 277 funds tracked by Wall St. Rank held ArcBest as of Q1 2026.

Based on Royce & Associates's 13F filing for Q1 2026, filed 12 May 2026.